| Income Statement |
| Total Revenue | 875.14M |
|
| Revenues (USD) | 875.14M |
| Cost of Revenue | 346.18M |
| Gross Profit | 528.96M |
| Operating Expenses | 321.85M |
| Research and Development Expense | 75.75M |
| Selling, General and Administrative Expense | 237.19M |
| Operating Income | 207.11M |
| Interest Expense | 94.05M |
| Income Tax Expense | 21.77M |
| Net Income | 91.10M |
| Net Income Common Stock | 91.10M |
| Net Income Common Stock (USD) | 91.10M |
| Consolidated Income | 91.10M |
| Earnings per Basic Share | 3.66 |
| Earnings per Basic Share (USD) | 3.66 |
| Earnings per Diluted Share | 3.46 |
| Earning Before Interest & Taxes (EBIT) | 206.91M |
| Earning Before Interest & Taxes (USD) | 206.91M |
| Weighted Average Shares | 24.87M |
| Weighted Average Shares Diluted | 26.35M |
| Balance Sheet |
| Cash and Equivalents | 421.36M |
| Cash and Equivalents (USD) | 421.36M |
| Investments | 5.87B |
| Trade and Non-Trade Receivables | 74.15M |
| Property, Plant & Equipment Net | 151.59M |
| Total Assets | 6.88B |
| Total Debt | 4.86B |
| Total Liabilities | 5.48B |
| Accumulated Retained Earnings (Deficit) | 2.10B |
| Accumulated Other Comprehensive Income | -6.41M |
| Shareholders Equity | 1.40B |
| Shareholders Equity (USD) | 1.40B |
| Total Debt (USD) | 4.86B |
| Goodwill and Intangible Assets | 281.69M |
| Trade and Non-Trade Payables | 282.11M |
| Tax Assets | 41.02M |
| Tax Liabilities | 329.10M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.91M |
| Net Cash Flow from Financing | 292.12M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 13.49M |
| Capital Expenditure | -10.75M |
| Issuance (Purchase) of Equity Shares | -37.84M |
| Issuance (Repayment) of Debt Securities | 329.96M |
| Net Cash Flow from Investing | -753.37M |
| Net Cash Flow - Investment Acquisitions and Disposals | -742.62M |
| Net Cash Flow from Operations | 474.54M |
| Effect of Exchange Rate Changes on Cash | 206.00K |
| Share Based Compensation | 8.71M |